Tests a robot-assisted method for brain blood vessel procedures
Tests a robotic device during brain blood vessel procedures in adults with stroke or meningioma.
Key facts
- Who runs it
- Navigantis Inc.
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- Robot-Assisted Neurovascular Intervention
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- 27 Dec 2024
- Expected to end
- 2 Dec 2026
- Type of study
- Interventional
- Treatments tested
- cerebral angiography, arterial embolization, thrombectomy
- Cerebral angiogram using robotic device
- Meningioma embolization using robotic device.
- Mechanical thrombectomy for stroke using a robotic device.
- Record updated
- 16 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are scheduled for a brain blood vessel procedure: cerebral angiography, embolization for meningioma, or thrombectomy for stroke. The procedure is done with a robot.
- Age
- 18 Years to 80 Years
- Sex
- All sexes
- Disease stage
- People scheduled for neurovascular procedures: diagnostic cerebral angiography, arterial embolization for meningioma, or thrombectomy for cerebral ischemia caused by a blocked artery.
- Earlier treatment
- No surgery within 4 weeks before joining, and fully recovered from any earlier surgery.
Main reasons for not taking part
- Pregnant or breastfeeding
- Allergy to the contrast agents used in angiography
- Kidney failure
- Heart attack or SVC syndrome within 3 months, or existing heart disease
- Severe or life-threatening other illnesses
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Patients scheduled for neurovascular interventions, such as diagnostic cerebral angiography for cerebrovascular diseases, arterial embolization for meningioma treatment, and thrombectomy for thrombotic arterial occlusion-induced cerebral ischemia, are selected according to the same criteria as standard cerebral angiography and interventional procedures
Who cannot take part
- Patients who have undergone surgery within 4 weeks prior to study participation or have not fully recovered from surgery
- Patients with a history of cardiac events, such as myocardial infarction or superior vena cava (SVC) syndrome, within 3 months prior to study participation, or with existing heart disease
- Patients where the intracranial occlusion is determined to be chronic based on clinical history, prior imaging, or clinical judgment
- Patients with existing or anticipated vasospasm, bleeding, or severe atheromatous disease
- Patients allergic to contrast agents used in angiography
- Patients with renal failure
- Patients suspected to have cerebral artery dissection or atherosclerosis as the cause of stroke
- Patients who are pregnant or breastfeeding
- Patients unable to cooperate due to difficulty in expressing intent to the extent that the procedure cannot proceed
- Patients with severe or life-threatening comorbidities that could significantly affect symptom improvement or render the procedure unbeneficial
- Patients with non-life-threatening comorbidities that prevent proper follow-up for treatment
- Patients with an ASPECTS score of 0-2 on a pre-treatment non-contrast CT
- Inability to perform femoral puncture within 60 minutes of completing CT angiography (if CT perfusion is performed, it must be done after CT angiography)
- Absence of a femoral pulse
- Cases where vascular access is highly challenging, with an anticipated time exceeding 90 minutes from CT angiography to reperfusion
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in South Korea
- Severence Hospital, Yonsei University College of MedicineSeoul, South KoreaContact: Haena KimTaking people
About the trial
What the trial wants to find out
Patients scheduled for neurovascular interventions may be eligible to have their procedure done robotically.
The group in the trial
- Robot Assisted Neurovascular InterventionTreatment being tested
Patients will undergo robot-assisted neurovascular interventions.
Treatment: cerebral angiography, arterial embolization, thrombectomy, Cerebral angiogram using robotic device, Meningioma embolization using robotic device., and Mechanical thrombectomy for stroke using a robotic device.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Robot-assisted Neurovascular Intervention for Patients Indicated for Angiography, Cerebral Artery Embolization, and Thrombectomy: Exploratory Study to Compare to Existing Interventional Procedures
- Plain-language title
- Tests a robot-assisted method for brain blood vessel proceduresGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06752096, who can take part
- Record updated
- 16 January 2026